<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="covidseq/PMC7144273/results/search/disease/results.xml">
  <result pre="have demonstrated safety and possible efficacy in patients with the" exact="acute respiratory distress syndrome" post="(ARDS), although not as yet well studied in respiratory"/>
  <result pre="mostly commonly characterised by fever (82%) and cough (81%). Severe" exact="pneumonia" post="and acute respiratory distress syndrome (ARDS) have been described"/>
  <result pre="characterised by fever (82%) and cough (81%). Severe pneumonia and" exact="acute respiratory distress syndrome" post="(ARDS) have been described in 14% of the reported"/>
  <result pre="other cell types, have been initiated in China for COVID-19" exact="respiratory disease." post="As these encompass a wide range of approaches and"/>
  <result pre="to inhibit the cytotoxicity of specific T cells against H1N1" exact="influenza" post="virus in vitro [ 18], leading perhaps to prolonged"/>
  <result pre="ameliorate SARS-CoV-2 lung damage based on limited pre-clinical data in" exact="influenza" post="infection models (lower right). Figure adapted from Laffey and"/>
  <result pre="cultured cells by many viruses, including dengue virus, Ebola virus," exact="influenza" post="A virus and SARS coronavirus [ 22]. Silencing of"/>
  <result pre="expressed ISGs in MSCs (p21/CDKN1A), specifically increased their susceptibility to" exact="chikungunya" post="virus (CHIKV), whereas knockdown of IFITM3 rendered MSC susceptible"/>
  <result pre="contrast, some literature demonstrates that human BM-MSCs are permissive to" exact="avian influenza" post="A (H5N1) infection, losing viability and immunoregulatory activities ["/>
  <result pre="some literature demonstrates that human BM-MSCs are permissive to avian" exact="influenza" post="A (H5N1) infection, losing viability and immunoregulatory activities ["/>
  <result pre="virus replication and lung inflammation [ 24– 27]. BM-MSCs express" exact="influenza" post="virus alpha-2,3 and alpha-2,6 sialic acid receptors on their"/>
  <result pre="and can support replication of both avian H1N1 and H9N5" exact="influenza" post="strains [ 24, 25]. Influenza-infected MSCs undergo cell lysis"/>
  <result pre="of respiratory virus infections. These have further been limited to" exact="influenza" post="viruses, have produced conflicting results, and have not as"/>
  <result pre="two earlier studies found MSCs not to be protective against" exact="influenza" post="respiratory infections in mice. Darwish and colleagues assessed the"/>
  <result pre="No BM-MSC-derived EVs: Decreased virus shedding in nasal swabs, Reduced" exact="influenza" post="virus replication in the lungs, Prevent virus-induced production of"/>
  <result pre="of systemic MSC administration in rodent and pig models of" exact="influenza" post="respiratory infections. Chan and colleagues found in in vitro"/>
  <result pre="fluid clearance and protein permeability induced by H5N1 and H7N9" exact="influenza" post="viruses, in part by releasing soluble mediators that up-regulated"/>
  <result pre="dealing with more clinically relevant sequelae of epithelial infection. Avian" exact="influenza" post="virus infection can trigger a very intense pro-inflammatory response"/>
  <result pre="can trigger a very intense pro-inflammatory response compared to other" exact="influenza" post="viruses; thus, authors speculated that the beneficial effects might"/>
  <result pre="MSCs was safe and reduced virus shedding in nasal swabs," exact="influenza" post="replication in the lungs, BALF pro-inflammatory cytokines and chemokines,"/>
  <result pre="infected with SARS-CoV-2 demonstrated virus replication in lung and interstitial" exact="pneumonia" post="with lymphocyte and monocytes infiltration into the alveolar interstitium"/>
  <result pre="of the administered MSCs by the viruses, particularly the Avian" exact="influenza" post="viruses, might explain the lack of effectiveness observed in"/>
  <result pre="of potential efficacy of MSC administration in pre-clinical models of" exact="influenza" post="respiratory viral lung infections, there are limited published clinical"/>
  <result pre="in Beijing administered BM-derived MSCs to seven patients with COVID-19" exact="pneumonia" post="with differing degrees of severity including one patient with"/>
  <result pre="recently published study evaluated MSC administration in patients with H7N9" exact="influenza" post="virus respiratory infections during the 2013–2014 outbreak in China"/>
  <result pre="cell infusion in the treatment of patients with severe 2019-nCoV" exact="pneumonia" post="(novel coronavirus pneumonia, NCP) MSCs Experimental group: Ruxolitinib combined"/>
  <result pre="cells (hucMSCs) in the treatment of high risk novel coronavirus" exact="pneumonia" post="(COVID-19) patients UC- MSCs Experimental group: MSCs Control group:"/>
  <result pre="study of mesenchymal stem cells in treating severe novel coronavirus" exact="pneumonia" post="(COVID- 19) MSCs Experimental group 1: critical group Intervention,"/>
  <result pre="cord mesenchymal stem cells for the treatment of novel coronavirus" exact="pneumonia" post="(COVID-19) and clinical application demonstration UC- MSCs Experimental group:"/>
  <result pre="human umbilical cord mesenchymal stem cells in the treatment of" exact="acute respiratory distress syndrome" post="of severe novel coronavirus pneumonia (COVID-19) UC- MSCs Experimental"/>
  <result pre="treatment of acute respiratory distress syndrome of severe novel coronavirus" exact="pneumonia" post="(COVID-19) UC- MSCs Experimental group: Different stem cell doses"/>
  <result pre="mesenchymal stem cells in the treatment of severe novel coronavirus" exact="pneumonia" post="(COVID- 19) UC-Whartons Jellys MSCs Experimental group: Iv injection"/>
  <result pre="research related to mesenchymal stem cells to treat novel coronavirus" exact="pneumonia" post="(COVID- 19) MSCs Experimental group: Case series: MSCs therapy"/>
  <result pre="cells for the treatment of pneumonitis caused by novel coronavirus" exact="pneumonia" post="(COVID- 19) MSCs Experimental group: MSCs Control group: Saline"/>
  <result pre="medium in the treatment of severe and critically novel coronavirus" exact="pneumonia" post="(COVID-19): a randomized controlled trial UC- MSCs CM Experimental"/>
  <result pre="stem cells exosomes atomization in the treatment of novel coronavirus" exact="pneumonia" post="(COVID-19) MSCs Exo Experimental group: Aerosol inhalation of exosomes"/>
  <result pre="cells in the treatment of severe and critically novel coronavirus" exact="pneumonia" post="(COVID-19): a randomized controlled clinical trial UCBMC Experimental group:"/>
  <result pre="treatment of mild and general patients infected with novel coronavirus" exact="pneumonia" post="(COVID- 19) CIK and NK Experimental group: CIK group:"/>
  <result pre="infections Activities of health care providers and researchers during an" exact="infectious disease" post="outbreak, including clinical trials, are aimed towards finding rapid"/>
  <result pre="currently recognised risk factors such as increased age, diabetes and/or" exact="cardiovascular disease" post="at potentially higher risk for clinical deterioration. In this"/>
  <result pre="data. The limited available data regarding MSC administration in pre-clinical" exact="respiratory disease" post="injury models and current understanding of potential mechanisms of"/>
  <result pre="Cells for Cells, a University spin-off developing therapies for Osteoarthritis," exact="pulpitis" post="and cardiac failure, and Regenero, a consortium for Chilean"/>
  <result pre="Cells for Cells, a University spin-off developing therapies for Osteoarthritis," exact="pulpitis" post="and cardiac failure, and Regenero, a consortium for Chilean"/>
  <result pre="W , et al. Mesenchymal stromal cell treatment prevents H9N2" exact="avian influenza" post="virus-induced acute lung injury in mice . Stem Cell"/>
  <result pre=", et al. Mesenchymal stromal cell treatment prevents H9N2 avian" exact="influenza" post="virus-induced acute lung injury in mice . Stem Cell"/>
  <result pre="of chicken lung mesenchymal stromal cells and their susceptibility to" exact="avian influenza" post="virus . Dev Comp Immunol 2010; 34: 474– 479."/>
  <result pre="chicken lung mesenchymal stromal cells and their susceptibility to avian" exact="influenza" post="virus . Dev Comp Immunol 2010; 34: 474– 479."/>
  <result pre="Kanrai P , Wiboon-ut S , et al. Tropism of" exact="avian influenza" post="a (H5N1) virus to mesenchymal stem cells and CD34+"/>
  <result pre="P , Wiboon-ut S , et al. Tropism of avian" exact="influenza" post="a (H5N1) virus to mesenchymal stem cells and CD34+"/>
  <result pre=", Rocco PRM Prospects and progress in cell therapy for" exact="acute respiratory distress syndrome." post="Expert Opin Biol Ther 2016; 16: 1353– 1360. doi:"/>
  <result pre="(stem) cell therapy fails to improve outcomes in experimental severe" exact="influenza" post=". PLoS One 2013; 8: e71761. doi: 10.1371/journal.pone.0071761 23967240"/>
  <result pre="Leung CYH , et al. Human mesenchymal stromal cells reduce" exact="influenza" post="A H5N1-associated acute lung injury in vitro and in"/>
  <result pre="LA , Meulia T Mesenchymal stem cell-derived extracellular vesicles attenuate" exact="influenza" post="virus-induced acute lung injury in a pig model ."/>
  <result pre="2019 — Article Clinical study of mesenchymal stem cell treating" exact="acute respiratory distress syndrome" post="induced by epidemic Influenza A (H7N9) infection, a hint"/>
  <result pre="the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected" exact="pneumonia" post="(standard version) . Mil Med Res 2020. 50 Matthay"/>
  <result pre="Treatment with allogeneic mesenchymal stromal cells for moderate to severe" exact="acute respiratory distress syndrome" post="(START study): a randomised phase 2a safety trial ."/>
  <result pre="30455077 51 Organisation WH Guidance for managing ethical issues in" exact="infectious disease" post="outbreaks. World Heal Organ 2016; 62. 52 Athersys Provides"/>
 </snippets>
</snippetsTree>
